Streetbeat News

Stock Prices

CYTK

Cytokinetics announced the topline results from its Phase 1 clinical study of CK-4021586, a new drug under development. The results could influence the company's future research directions and investor sentiment.

Portfolio Pulse from Benzinga Newsdesk

May 08, 2024 | 11:48 am

WHF

WhiteHorse Finance (WHF) reported Q1 2024 adjusted EPS of $0.47, surpassing the $0.46 estimate, and sales of $25.475M, exceeding the $24.880M forecast. This represents a slight increase in EPS and a minor decrease in sales compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

May 08, 2024 | 11:43 am

ADN

CDRE

HII

Three industrial stocks, Advent Technologies Holdings, Inc. (ADN), Cadre Holdings, Inc. (CDRE), and Huntington Ingalls Industries, Inc. (HII), are highlighted as oversold with RSI values below 30, indicating potential for short-term gains. ADN recently underwent a 1-for-30 reverse stock split, CDRE reported increased net sales and gross margin, and HII showed strong quarterly revenue growth.

Portfolio Pulse from Avi Kapoor

May 08, 2024 | 11:43 am

LL

LL Flooring Holdings shares dropped after reporting disappointing Q1 earnings and announced it will not provide financial guidance due to macroeconomic uncertainty.

Portfolio Pulse from Benzinga Newsdesk

May 08, 2024 | 11:43 am

BRK

BYDDF

TSLA

Gary Black, a Tesla investor and Future Fund Managing Partner, believes Warren Buffett's Berkshire Hathaway is unlikely to invest in Tesla due to its high valuation and Buffett's preference for value stocks. Black points out that Tesla's estimated earnings per share for 2024 are trading at 70 times, making it an expensive choice for Berkshire. Instead, Buffett's investments in Apple and BYD are highlighted as more aligned with his investment philosophy, with both companies having more reasonable valuations at the time of Berkshire's investment.

Portfolio Pulse from Shanthi Rexaline

May 08, 2024 | 11:40 am

KPTI

Karyopharm Therapeutics (KPTI) reported Q1 2024 earnings with a GAAP EPS of $(0.32), slightly beating the $(0.33) estimate. However, their sales of $33.126M fell short of the $34.473M estimate, marking a 14.40% decrease from the previous year.

Portfolio Pulse from Benzinga Newsdesk

May 08, 2024 | 11:38 am

RIVN

Needham analyst Chris Pierce reiterated a Buy rating on Rivian Automotive (NASDAQ:RIVN) and maintained a $13 price target. This reaffirms Needham's positive outlook on Rivian's stock.

Portfolio Pulse from Benzinga Newsdesk

May 08, 2024 | 11:37 am

MCFT

MasterCraft Boat Holdings, Inc. has revised its FY24 financial outlook downwards due to a planned decrease in production. The company now expects consolidated net sales to range between $360M-$365M, down from the previously forecasted $400M-$412M. Additionally, the adjusted EPS forecast has been lowered from $1.53 - $1.78 to $0.95 - $1.05, against an analyst estimate of $1.60.

Portfolio Pulse from Benzinga Newsdesk

May 08, 2024 | 11:36 am

HLLY

Holley (NYSE:HLLY) reported Q1 sales of $158.636M, surpassing the analyst consensus estimate of $154.935M by 2.39%, but marking a 7.88% decrease from the previous year's sales of $172.205M.

Portfolio Pulse from Benzinga Newsdesk

May 08, 2024 | 11:36 am

MHH

Mastech Digital (AMEX:MHH) reported Q1 2024 earnings of $0.06 per share, missing the consensus estimate of $0.12 by 50%. Sales were $46.823M, slightly above the $46.496M estimate but represent a 14.96% decrease from the previous year.

Portfolio Pulse from Benzinga Newsdesk

May 08, 2024 | 11:35 am